SCHEMBL7216401

SCHEMBL7216401

[CH2]c1nc2c(F)cccc2s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 10/20 0.61
RAB9A P51151 10/20 0.59
NPC1 O15118 9/20 0.59
ALDH1A1 P00352 8/20 0.59
GAA P10253 8/20 0.59
MEN1 O00255 8/20 0.59
KMT2A Q03164 8/20 0.59
HPGD P15428 7/20 0.59
KDM4E B2RXH2 7/20 0.59
LMNA P02545 6/20 0.59
PRNP P04156 1/20 0.59
MAPT P10636 6/20 0.56
L3MBTL1 Q9Y468 1/20 0.51
CASP3 P42574 2/20 0.50
SENP8 Q96LD8 2/20 0.50
SENP7 Q9BQF6 2/20 0.50
SENP6 Q9GZR1 2/20 0.50
MAPK1 P28482 1/20 0.50
TSHR P16473 1/20 0.50
POLB P06746 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5892826 0.79 SMN1; SMN2 (0.66) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL3077601 0.78 SMN1; SMN2 (0.67) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL7216455 0.77 SMN1; SMN2 (0.58) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL2623678 0.76 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL7698118 0.76 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL9260123 0.76 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL2634141 0.76 SMN1; SMN2 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL2015529 0.76 ALDH1A1 (0.61) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL102844 0.76 SMN1; SMN2 (1.00) SMN1; SMN2RAB9ANPC1ALDH1A1GAA
SCHEMBL30874518 0.73 PSMB8 (0.67) SMN1; SMN2RAB9ANPC1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576765-B2 Process for preparing amic acid esters IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-06-10 US disclosed
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2003-02-13 US disclosed
EP-1182199-A1 PROCESS FOR PREPARING AMIC ACID ESTERS IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032667-A1 PROCESS FOR PREPARING AMIC ACID ESTERS MCCC2, EMC1, GANC SMN1; SMN2 4168/4885RAB9A 774/4885NPC1 2798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.